Involvement	O
of	O
the	O
N-terminal	B-protein
region	I-protein
of	O
the	O
human	B-protein
mineralocorticoid	I-protein
receptor	I-protein
hormone-binding	I-protein
domain	I-protein
in	O
agonist	O
and	O
antagonist	O
binding	O
as	O
revealed	O
by	O
a	O
new	B-protein
monoclonal	I-protein
antibody	I-protein
.	O

To	O
gain	O
a	O
better	O
understanding	O
of	O
the	O
mechanism	O
of	O
binding	O
to	O
the	O
human	B-protein
mineralocorticoid	I-protein
receptor	I-protein
(	O
hMR	B-protein
)	O
,	O
we	O
developed	O
a	O
new	O
monoclonal	B-protein
antibody	I-protein
(	O
mAb	B-protein
)	O
raised	O
against	O
the	O
hormone-binding	B-protein
domain	I-protein
(	O
HBD	B-protein
)	O
.	O

For	O
this	O
purpose	O
,	O
mice	O
were	O
immunized	O
with	O
a	O
fusion	B-protein
protein	I-protein
including	O
the	O
sequence	O
Thr729-Lys984	B-protein
of	O
hMR	B-protein
.	O

After	O
ELISA	O
screening	O
,	O
mAb	B-protein
18C7	I-protein
was	O
selected	O
for	O
its	O
specificity	O
towards	O
the	O
HBD	B-protein
.	O

This	O
antibody	O
recognized	O
both	O
the	O
denatured	O
and	O
native	B-protein
MR	I-protein
forms	I-protein
,	O
as	O
well	O
as	O
the	O
hetero-oligomeric	B-protein
MR	I-protein
form	I-protein
and	O
the	O
transformed	B-protein
MR	I-protein
state	I-protein
.	O

By	O
using	O
several	O
HBD	B-protein
subfragments	I-protein
,	O
the	O
mAb	B-protein
18C7	I-protein
epitope	I-protein
was	O
located	O
in	O
the	O
N-terminal	B-protein
region	I-protein
of	O
the	O
HBD	B-protein
from	O
Thr729	B-protein
to	I-protein
Leu765	I-protein
.	O

We	O
then	O
studied	O
the	O
effect	O
of	O
the	O
antibody	O
on	O
aldosterone	O
and	O
progesterone	O
binding	O
to	O
the	O
hMR	B-protein
.	O

When	O
18C7	B-protein
was	O
incubated	O
with	O
liganded	B-protein
MR	I-protein
,	O
it	O
was	O
able	O
to	O
partly	O
displace	O
(	O
20	O
%	O
)	O
the	O
hormone	O
from	O
its	O
binding	O
site	O
.	O

When	O
18C7	B-protein
was	O
incubated	O
with	O
MR	B-protein
before	O
aldosterone	O
or	O
progesterone	O
,	O
the	O
antibody	O
inhibited	O
75-80	O
%	O
of	O
the	O
binding	O
.	O

The	O
effect	O
of	O
18C7	B-protein
on	O
the	O
binding	O
was	O
similar	O
with	O
both	O
hormones	O
.	O

A	O
sucrose	O
gradient	O
analysis	O
indicated	O
the	O
simultaneous	O
presence	O
of	O
two	O
kinds	O
of	O
receptor	O
complexes	O
:	O
the	O
steroid-MR	B-protein
complex	I-protein
and	O
the	O
antibody-MR	B-protein
complex	I-protein
.	O

After	O
its	O
associated	O
proteins	O
,	O
especially	O
the	O
heat-shock	B-protein
protein	I-protein
hsp90	I-protein
,	O
had	O
been	O
cross-linked	O
with	O
the	O
hMR	B-protein
by	O
dimethylpimelimidate	O
,	O
18C7	B-protein
was	O
still	O
able	O
to	O
react	O
with	O
the	O
receptor	O
.	O

Our	O
results	O
indicated	O
that	O
the	O
epitope	B-protein
recognized	O
by	O
18C7	B-protein
was	O
directly	O
implicated	O
in	O
hormone	O
binding	O
.	O

The	O
lack	O
of	O
steroid	O
binding	O
of	O
HBD	B-protein
mutants	O
with	O
the	O
Thr729-Leu765	B-protein
sequence	I-protein
deleted	O
[	O
Jalaguier	O
,	O
Mesnier	O
,	O
Leger	O
and	O
Auzou	O
(	O
1996	O
)	O
J.Steroid	O
Biochem.Mol.Biol.57	O
,	O
43-50	O
]	O
supports	O
this	O
hypothesis	O
.	O

Because	O
of	O
the	O
similar	O
behaviours	O
of	O
aldosterone	O
and	O
progesterone	O
,	O
we	O
conclude	O
that	O
the	O
N-terminal	B-protein
Thr729-Leu765	I-protein
region	I-protein
of	O
the	O
HBD	B-protein
is	O
similarly	O
involved	O
in	O
the	O
binding	O
of	O
both	O
hormones	O
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
324	NULL
,	NULL
57-683	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
57	NULL
Involvement	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
human	NULL
mineralocorticoid	NULL
receptor	NULL
hormone-binding	NULL
domain	NULL
in	NULL
agonist	NULL
and	NULL
antagonist	NULL
binding	NULL
as	NULL
revealed	NULL
by	NULL
a	NULL
new	NULL
monoclonal	NULL
antibody	NULL
Stéphan	NULL
JALAGUIER*f	NULL
,	NULL
Brigitte	NULL
LUPO*f§	NULL
,	NULL
Gérald	NULL
HUGON®	NULL
,	NULL
Marie-Edith	NULL
and	NULL
Gilles	NULL
AUZOU*	NULL
*INSERM	NULL
U300	NULL
,	NULL
Faculté	NULL
de	NULL
Pharmacie	NULL
Bat	NULL
.	NULL

K	NULL
,	NULL
15	NULL
Avenue	NULL
Charles	NULL
Flahault	NULL
,	NULL
34060	NULL
Montpellier	NULL
Cedex	NULL
2	NULL
,	NULL
France	NULL
,	NULL
and	NULL
fINSERM	NULL
U246	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
Xavier	NULL
Bichat	NULL
,	NULL
16	NULL
Rue	NULL
Henri	NULL
Huchard	NULL
,	NULL
BP	NULL
416	NULL
,	NULL
75870	NULL
Paris	NULL
Cedex	NULL
18	NULL
,	NULL
France	NULL
To	NULL
gain	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
mineralocorticoid	NULL
receptor	NULL
(	NULL
hMR	NULL
)	NULL
,	NULL
we	NULL
developed	NULL
a	NULL
new	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
raised	NULL
against	NULL
the	NULL
hormone-binding	NULL
domain	NULL
(	NULL
HBD	NULL
)	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
mice	NULL
were	NULL
immunized	NULL
with	NULL
a	NULL
fusion	NULL
protein	NULL
including	NULL
the	NULL
sequence	NULL
of	NULL
hMR	NULL
.	NULL

After	NULL
ELISA	NULL
screening	NULL
,	NULL
mAb	NULL
18C7	NULL
was	NULL
selected	NULL
for	NULL
its	NULL
specificity	NULL
towards	NULL
the	NULL
HBD	NULL
.	NULL

This	NULL
antibody	NULL
recognized	NULL
both	NULL
the	NULL
denatured	NULL
and	NULL
native	NULL
MR	NULL
forms	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
hetero-oligomeric	NULL
MR	NULL
form	NULL
and	NULL
the	NULL
transformed	NULL
MR	NULL
state	NULL
.	NULL

By	NULL
using	NULL
several	NULL
HBD	NULL
subfragments	NULL
,	NULL
the	NULL
mAb	NULL
18C7	NULL
epitope	NULL
was	NULL
located	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
HBD	NULL
from	NULL
Thr'*	NULL
``	NULL
to	NULL
Leu	NULL
``	NULL
``	NULL
``	NULL
.	NULL

We	NULL
then	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antibody	NULL
on	NULL
aldosterone	NULL
and	NULL
progesterone	NULL
binding	NULL
to	NULL
the	NULL
hMR	NULL
.	NULL

When	NULL
18C7	NULL
was	NULL
incubated	NULL
with	NULL
liganded	NULL
MR	NULL
,	NULL
it	NULL
was	NULL
able	NULL
to	NULL
partly	NULL
displace	NULL
(	NULL
20	NULL
%	NULL
)	NULL
the	NULL
hormone	NULL
from	NULL
its	NULL
binding	NULL
site	NULL
.	NULL

When	NULL
18C:7	NULL
was	NULL
incubated	NULL
with	NULL
MR	NULL
before	NULL
aldosterone	NULL
or	NULL
progesterone	NULL
,	NULL
the	NULL
antibody	NULL
inhibited	NULL
75-80	NULL
%	NULL
of	NULL
the	NULL
binding	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
18C7	NULL
on	NULL
the	NULL
binding	NULL
was	NULL
similar	NULL
with	NULL
both	NULL
hormones	NULL
.	NULL

A	NULL
sucrose	NULL
gradient	NULL
analysis	NULL
indicated	NULL
the	NULL
simultaneous	NULL
presence	NULL
of	NULL
two	NULL
kinds	NULL
of	NULL
receptor	NULL
complexes	NULL
:	NULL
the	NULL
steroid-MR	NULL
complex	NULL
and	NULL
the	NULL
antibody-MR	NULL
complex	NULL
.	NULL

After	NULL
its	NULL
associated	NULL
proteins	NULL
,	NULL
especially	NULL
the	NULL
heat-shock	NULL
protein	NULL
hsp90	NULL
,	NULL
had	NULL
been	NULL
cross-linked	NULL
with	NULL
the	NULL
hMR	NULL
by	NULL
dimethylpimelimidate	NULL
,	NULL
18C7	NULL
was	NULL
still	NULL
able	NULL
to	NULL
react	NULL
with	NULL
the	NULL
receptor	NULL
.	NULL

Our	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
epitope	NULL
recognized	NULL
by	NULL
18C7	NULL
was	NULL
directly	NULL
implicated	NULL
in	NULL
hormone	NULL
binding	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
steroid	NULL
binding	NULL
of	NULL
HBD	NULL
mutants	NULL
with	NULL
the	NULL
Thr'**-Leu	NULL
``	NULL
``	NULL
``	NULL
sequence	NULL
deleted	NULL
[	NULL
Jalaguier	NULL
,	NULL
Mesnier	NULL
,	NULL
Léger	NULL
and	NULL
Auzou	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

57	NULL
,	NULL
43-50	NULL
]	NULL
supports	NULL
this	NULL
hypothesis	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
similar	NULL
behaviours	NULL
of	NULL
aldosterone	NULL
and	NULL
progesterone	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
HBD	NULL
is	NULL
similarly	NULL
involved	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
both	NULL
hormones	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
human	NULL
mineralocorticoid	NULL
receptor	NULL
(	NULL
hMR	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
steroid	NULL
hormone	NULL
receptor	NULL
family	NULL
[	NULL
1	NULL
]	NULL
.	NULL

The	NULL
hMR	NULL
,	NULL
as	NULL
part	NULL
of	NULL
this	NULL
family	NULL
[	NULL
2,3	NULL
]	NULL
,	NULL
has	NULL
been	NULL
characterized	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
functional	NULL
domains	NULL
related	NULL
to	NULL
ligand	NULL
binding	NULL
,	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Owing	NULL
to	NULL
its	NULL
long	NULL
N-terminal	NULL
region	NULL
,	NULL
the	NULL
hMBR	NULL
is	NULL
larger	NULL
than	NULL
other	NULL
steroid	NULL
receptors	NULL
with	NULL
its	NULL
984-residue	NULL
sequence	NULL
.	NULL

It	NULL
is	NULL
most	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
:	NULL
their	NULL
DNA-binding	NULL
domains	NULL
share	NULL
approximately	NULL
94	NULL
%	NULL
similarity	NULL
,	NULL
whereas	NULL
their	NULL
C-terminal	NULL
hormone-binding	NULL
domains	NULL
(	NULL
HBDs	NULL
)	NULL
show	NULL
57	NULL
%	NULL
similarity	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
providing	NULL
structural	NULL
features	NULL
for	NULL
the	NULL
hormone-binding	NULL
site	NULL
,	NULL
the	NULL
250-residue	NULL
C-terminus	NULL
is	NULL
assumed	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
multiple	NULL
functions	NULL
of	NULL
this	NULL
receptor	NULL
because	NULL
it	NULL
harbours	NULL
a	NULL
ligand-dependent	NULL
transcriptional	NULL
activation	NULL
factor	NULL
and	NULL
a	NULL
hormone-dependent	NULL
nuclear	NULL
localization	NULL
signal	NULL
.	NULL

This	NULL
domain	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
receptor	NULL
dimerization	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
heat-shock	NULL
proteins	NULL
(	NULL
hsps	NULL
)	NULL
,	NULL
and	NULL
recently	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
actin	NULL
[	NULL
4	NULL
]	NULL
.	NULL

As	NULL
for	NULL
the	NULL
other	NULL
members	NULL
of	NULL
the	NULL
family	NULL
,	NULL
unliganded	NULL
hMR	NULL
is	NULL
a	NULL
soluble	NULL
hetero-oligomeric	NULL
complex	NULL
that	NULL
includes	NULL
hsp90	NULL
[	NULL
5,6	NULL
]	NULL
and	NULL
probably	NULL
other	NULL
receptor-associated	NULL
proteins	NULL
(	NULL
hsp70	NULL
and	NULL
hsp56	NULL
)	NULL
(	NULL
reviewed	NULL
in	NULL
[	NULL
7,8	NULL
]	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
these	NULL
associated	NULL
proteins	NULL
is	NULL
necessary	NULL
for	NULL
binding	NULL
the	NULL
physiological	NULL
hMBR	NULL
ligand	NULL
,	NULL
the	NULL
steroid	NULL
hormone	NULL
aldosterone	NULL
[	NULL
6,9	NULL
]	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
natural	NULL
antagonist	NULL
progesterone	NULL
and	NULL
synthetic	NULL
anti-mineralocorticoid	NULL
spirolactones	NULL
.	NULL

After	NULL
binding	NULL
the	NULL
ligand	NULL
,	NULL
a	NULL
conformational	NULL
change	NULL
occurs	NULL
in	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
the	NULL
hMR	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
agonists	NULL
and	NULL
antagonists	NULL
induce	NULL
different	NULL
hMR	NULL
conformations	NULL
[	NULL
10,11	NULL
]	NULL
.	NULL

Then	NULL
dissociation	NULL
of	NULL
hsp90	NULL
occurs	NULL
,	NULL
a	NULL
process	NULL
known	NULL
as	NULL
activation	NULL
or	NULL
transformation	NULL
,	NULL
which	NULL
provides	NULL
the	NULL
DNA-binding	NULL
form	NULL
of	NULL
hMR	NULL
.	NULL

MR	NULL
antibodies	NULL
were	NULL
mainly	NULL
produced	NULL
for	NULL
the	NULL
purpose	NULL
of	NULL
localizing	NULL
the	NULL
receptor	NULL
and	NULL
were	NULL
raised	NULL
against	NULL
preselected	NULL
peptide	NULL
sequences	NULL
located	NULL
on	NULL
the	NULL
N-terminal	NULL
region	NULL
[	NULL
12-14	NULL
]	NULL
or	NULL
derived	NULL
from	NULL
the	NULL
hinge	NULL
region	NULL
[	NULL
15	NULL
]	NULL
.	NULL

Only	NULL
one	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
H10E	NULL
)	NULL
recognized	NULL
the	NULL
ligand-binding	NULL
site	NULL
of	NULL
hMR	NULL
[	NULL
16	NULL
]	NULL
,	NULL
but	NULL
because	NULL
H10E	NULL
was	NULL
elicited	NULL
as	NULL
an	NULL
anti-idiotypic	NULL
antibody	NULL
against	NULL
aldosterone	NULL
,	NULL
its	NULL
usefulness	NULL
has	NULL
been	NULL
somewhat	NULL
limited	NULL
.	NULL

New	NULL
probes	NULL
were	NULL
required	NULL
for	NULL
functional	NULL
studies	NULL
of	NULL
the	NULL
structurally	NULL
complex	NULL
HBD	NULL
.	NULL

We	NULL
thus	NULL
developed	NULL
a	NULL
new	NULL
mAb	NULL
(	NULL
18C7	NULL
)	NULL
to	NULL
that	NULL
domain	NULL
by	NULL
immunizing	NULL
mice	NULL
with	NULL
the	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-HBD	NULL
fusion	NULL
protein	NULL
,	NULL
which	NULL
links	NULL
GST	NULL
with	NULL
the	NULL
255-residue	NULL
C-terminus	NULL
of	NULL
hMR	NULL
from	NULL
Thr'*	NULL
to	NULL
Lys®***	NULL
[	NULL
9	NULL
]	NULL
.	NULL

The	NULL
18C7	NULL
epitope	NULL
,	NULL
located	NULL
in	NULL
the	NULL
N-terminal	NULL
part	NULL
of	NULL
the	NULL
HBD	NULL
,	NULL
Abbreviations	NULL
used	NULL
:	NULL
DMP	NULL
,	NULL
dimethylpimelimidate	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
GR	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
;	NULL
HBD	NULL
,	NULL
hormone-binding	NULL
domain	NULL
;	NULL
hMR	NULL
,	NULL
human	NULL
mineralocorticoid	NULL
receptor	NULL
;	NULL
hsp	NULL
,	NULL
heat-shock	NULL
protein	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
MBP	NULL
,	NULL
maltose-binding	NULL
protein	NULL
;	NULL
MR	NULL
,	NULL
mineralocorticoid	NULL
receptor	NULL
.	NULL

{	NULL
Considered	NULL
jointly	NULL
as	NULL
first	NULL
authors	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

58	NULL
S.	NULL
Jalaguier	NULL
and	NULL
others	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
a	NULL
common	NULL
region	NULL
involved	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
aldosterone	NULL
(	NULL
mineralocorticoid	NULL
agonist	NULL
)	NULL
and	NULL
progesterone	NULL
(	NULL
mineralocorticoid	NULL
antagonist	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Chemicals	NULL
D-	NULL
[	NULL
1,2-H	NULL
(	NULL
N	NULL
)	NULL
]	NULL
Aldosterone	NULL
(	NULL
52	NULL
Ci/mmol	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
DuPont-New	NULL
England	NULL
Nuclear	NULL
(	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
.	NULL

[	NULL
1,2,6,7-*HProgesterone	NULL
(	NULL
92	NULL
Ci/mmol	NULL
)	NULL
,	NULL
L-	NULL
[	NULL
**SJmethionine	NULL
(	NULL
more	NULL
than	NULL
1000	NULL
Ci/mmol	NULL
!	NULL
)	NULL

and	NULL
[	NULL
``	NULL
C	NULL
)	NULL
Jmethylated	NULL
protein	NULL
molecular	NULL
mass	NULL
markers	NULL
(	NULL
10-100	NULL
wCi/mg	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Amersham	NULL
(	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Unlabelled	NULL
aldosterone	NULL
and	NULL
progesterone	NULL
were	NULL
from	NULL
Sigma	NULL
(	NULL
Saint	NULL
Quentin	NULL
Fallavier	NULL
,	NULL
France	NULL
)	NULL
.	NULL

DEAE-cellulose	NULL
DES52	NULL
was	NULL
from	NULL
Whatman	NULL
(	NULL
Clifton	NULL
,	NULL
NJ	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

The	NULL
TNT	NULL
T7	NULL
Coupled	NULL
Reticulocyte	NULL
Lysate	NULL
System	NULL
was	NULL
from	NULL
Promega	NULL
(	NULL
Charbonnieres	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Dimethylpimelimidate	NULL
(	NULL
DMP	NULL
)	NULL
was	NULL
from	NULL
Sigma	NULL
.	NULL

Amplify	NULL
was	NULL
purchased	NULL
from	NULL
Amersham	NULL
.	NULL

All	NULL
other	NULL
chemicals	NULL
were	NULL
of	NULL
reagent	NULL
grade	NULL
and	NULL
obtained	NULL
from	NULL
commercial	NULL
sources	NULL
.	NULL

Plasmids	NULL
and	NULL
vectors	NULL
The	NULL
phMR3750	NULL
plasmid	NULL
,	NULL
containing	NULL
the	NULL
full-length	NULL
hMR-coding	NULL
sequence	NULL
under	NULL
control	NULL
of	NULL
the	NULL
T7	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
pRShMR	NULL
plasmid	NULL
,	NULL
containing	NULL
the	NULL
hMR	NULL
coding	NULL
sequence	NULL
under	NULL
control	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
,	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
R.	NULL
M.	NULL
Evans	NULL
and	NULL
Dr.	NULL
J.	NULL
L.	NULL
Arriza	NULL
(	NULL
The	NULL
Salk	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
,	NULL
U.S.A.	NULL
)	NULL
[	NULL
1	NULL
]	NULL
.	NULL

pIH902	NULL
,	NULL
a	NULL
vector	NULL
of	NULL
the	NULL
pMAL-2	NULL
series	NULL
,	NULL
including	NULL
the	NULL
malE	NULL
gene	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
maltose-binding	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Ozyme	NULL
,	NULL
Montigny-le-Bretonneux	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Buffers	NULL
TEG	NULL
buffer	NULL
contained	NULL
20	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
and	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
.	NULL

TEGW	NULL
and	NULL
TEGMo	NULL
buffers	NULL
were	NULL
TEG	NULL
containing	NULL
20	NULL
mM	NULL
sodium	NULL
tungstate	NULL
or	NULL
20	NULL
mM	NULL
sodium	NULL
molybdate	NULL
respect-ively	NULL
.	NULL

TEGK	NULL
buffer	NULL
was	NULL
TEG	NULL
supplemented	NULL
with	NULL
0.4	NULL
M	NULL
KCI	NULL
.	NULL

All	NULL
buffers	NULL
were	NULL
adjusted	NULL
to	NULL
pH	NULL
7.4	NULL
at	NULL
25	NULL
°C	NULL
.	NULL

Antibody	NULL
generation	NULL
The	NULL
mouse	NULL
mAb	NULL
18C7	NULL
was	NULL
generated	NULL
by	NULL
injecting	NULL
mice	NULL
with	NULL
a	NULL
total	NULL
bacterial	NULL
inclusion	NULL
body	NULL
preparation	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
GST-HBD	NULL
[	NULL
T729-K984	NULL
]	NULL
[	NULL
9	NULL
]	NULL
.	NULL

Primary	NULL
screening	NULL
was	NULL
performed	NULL
by	NULL
ELISA	NULL
with	NULL
bacterial	NULL
recombinant	NULL
GST-HBD	NULL
,	NULL
MBP-HBD	NULL
[	NULL
9	NULL
]	NULL
,	NULL
GST	NULL
and	NULL
MBP	NULL
used	NULL
as	NULL
antigens	NULL
.	NULL

One	NULL
hybridoma	NULL
was	NULL
immunoreactive	NULL
against	NULL
both	NULL
GST-HBD	NULL
and	NULL
MBP-HBD	NULL
,	NULL
but	NULL
not	NULL
against	NULL
the	NULL
unfused	NULL
GST	NULL
and	NULL
MBP	NULL
.	NULL

It	NULL
was	NULL
clonally	NULL
purified	NULL
by	NULL
limiting	NULL
dilution	NULL
.	NULL

The	NULL
resulting	NULL
mAb	NULL
(	NULL
18C:7	NULL
)	NULL
was	NULL
subtyped	NULL
by	NULL
ELISA	NULL
by	NULL
using	NULL
a	NULL
mouse-hybridoma	NULL
subtyping	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Meylan	NULL
,	NULL
France	NULL
)	NULL
:	NULL
18C7	NULL
was	NULL
an	NULL
IgG1	NULL
with	NULL
a	NULL
«	NULL
light	NULL
chain	NULL
.	NULL

After	NULL
ascite	NULL
production	NULL
,	NULL
18C7	NULL
was	NULL
purified	NULL
at	NULL
2	NULL
mg/ml	NULL
concentration	NULL
by	NULL
chromatography	NULL
on	NULL
a	NULL
DEAE-cellulose	NULL
(	NULL
DES2	NULL
)	NULL
column	NULL
.	NULL

Construction	NULL
and	NULL
expression	NULL
of	NULL
receptor	NULL
fragments	NULL
Several	NULL
HBD	NULL
fragments	NULL
were	NULL
produced	NULL
as	NULL
fusion	NULL
proteins	NULL
with	NULL
MBP	NULL
by	NULL
cloning	NULL
inserts	NULL
into	NULL
the	NULL
pIH902	NULL
vector	NULL
in	NULL
accordance	NULL
with	NULL
a	NULL
previously	NULL
described	NULL
protocol	NULL
[	NULL
9	NULL
]	NULL
.	NULL

Fragments	NULL
HBD	NULL
[	NULL
L766-K984	NULL
]	NULL
and	NULL
HBD	NULL
[	NULL
T729-E940	NULL
]	NULL
were	NULL
as	NULL
previously	NULL
described	NULL
[	NULL
9	NULL
]	NULL
.	NULL

Fragments	NULL
HBD	NULL
[	NULL
T729-G915	NULL
]	NULL
and	NULL
HBD	NULL
[	NULL
L766-G915	NULL
]	NULL
were	NULL
obtained	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
parental	NULL
HBD	NULL
cDNA	NULL
with	NULL
the	NULL
following	NULL
primers	NULL
,	NULL
thus	NULL
introducing	NULL
the	NULL
BamHI	NULL
(	NULL
5	NULL
'	NULL
site	NULL
)	NULL
and	NULL
HindIII	NULL
(	NULL
3	NULL
site	NULL
)	NULL
cloning	NULL
sites	NULL
:	NULL
5	NULL
``	NULL
-CCCGGATCCACAATCTCACGAGCGCTCACA-3	NULL
'	NULL
(	NULL
forward	NULL
primer	NULL
for	NULL
[	NULL
1T729-G915	NULL
]	NULL
with	NULL
a	NULL
BamHI	NULL
site	NULL
underlined	NULL
)	NULL
,	NULL
CCCGGATCCCTCTCCACGCTCAACCGCTTA-3	NULL
'	NULL
(	NULL
forward	NULL
primer	NULL
for	NULL
[	NULL
L766-G915	NULL
]	NULL
with	NULL
a	NULL
BamHI	NULL
site	NULL
underlined	NULL
)	NULL
and	NULL
5'-CCCAAGCTTTCACCCAGAATTGTTGGGACACTTAG-Y	NULL
(	NULL
reverse	NULL
primer	NULL
for	NULL
both	NULL
fragments	NULL
with	NULL
a	NULL
HindIII	NULL
site	NULL
under-lined	NULL
)	NULL
.	NULL

After	NULL
digestion	NULL
with	NULL
BamHI	NULL
and	NULL
HindIII	NULL
,	NULL
the	NULL
PCR	NULL
product	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
previously	NULL
digested	NULL
pIH902	NULL
.	NULL

Fragments	NULL
HBD	NULL
[	NULL
T729-L862	NULL
]	NULL
and	NULL
HBD	NULL
[	NULL
L862-K984	NULL
]	NULL
were	NULL
obtained	NULL
by	NULL
cleavage	NULL
of	NULL
the	NULL
parental	NULL
HBD	NULL
cDNA	NULL
(	NULL
digestion	NULL
with	NULL
BamHI-Pstl	NULL
and	NULL
HindIII-Pstfl	NULL
respectively	NULL
)	NULL
.	NULL

Both	NULL
fragments	NULL
were	NULL
inserted	NULL
into	NULL
pIH902	NULL
,	NULL
previously	NULL
digested	NULL
with	NULL
BamHI	NULL
or	NULL
HindIII	NULL
respectively	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
blunting	NULL
step	NULL
with	NULL
Klenow	NULL
fragment	NULL
.	NULL

After	NULL
electrotransformation	NULL
of	NULL
Escherichia	NULL
coli	NULL
TBI	NULL
strains	NULL
with	NULL
the	NULL
corresponding	NULL
plasmid	NULL
,	NULL
the	NULL
recombinant	NULL
proteins	NULL
were	NULL
expressed	NULL
as	NULL
previously	NULL
described	NULL
[	NULL
9	NULL
]	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
aldosterone	NULL
and	NULL
progesterone	NULL
was	NULL
assayed	NULL
with	NULL
the	NULL
HBD	NULL
fragments	NULL
by	NULL
the	NULL
protocol	NULL
previously	NULL
described	NULL
[	NULL
9	NULL
]	NULL
.	NULL

hMR	NULL
transcription	NULL
and	NULL
translation	NULL
in	NULL
vifro	NULL
Full	NULL
hMR	NULL
was	NULL
expressed	NULL
in	NULL
vitro	NULL
directly	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
:	NULL
phMR3750	NULL
,	NULL
containing	NULL
the	NULL
full-length	NULL
hMR-coding	NULL
sequence	NULL
under	NULL
control	NULL
of	NULL
the	NULL
T7	NULL
promoter	NULL
,	NULL
was	NULL
transcribed	NULL
with	NULL
T7	NULL
RNA	NULL
polymerase	NULL
and	NULL
simultaneously	NULL
translated	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
for	NULL
1h	NULL
at	NULL
30°C	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
protocol	NULL
recommended	NULL
by	NULL
Promega	NULL
.	NULL

When	NULL
specified	NULL
,	NULL
MR	NULL
was	NULL
labelled	NULL
by	NULL
incorporation	NULL
of	NULL
L-	NULL
[	NULL
**SJmethionine	NULL
.	NULL

Covalent	NULL
cross-linking	NULL
The	NULL
cross-linking	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
by	NULL
Rafestin-Oblin	NULL
et	NULL
al	NULL
.	NULL

[	NULL
5	NULL
]	NULL
.	NULL

The	NULL
hMR	NULL
expressed	NULL
in	NULL
the	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
was	NULL
diluted	NULL
(	NULL
1	NULL
:	NULL
1	NULL
,	NULL
v/v	NULL
)	NULL
in	NULL
cold	NULL
TEGMo	NULL
.	NULL

To	NULL
100	NULL
wl	NULL
aliquots	NULL
of	NULL
MR	NULL
was	NULL
added	NULL
one-tenth	NULL
vol	NULL
.	NULL

of	NULL
2.2	NULL
M	NULL
triethanolamine	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
to	NULL
adjust	NULL
the	NULL
pH	NULL
and	NULL
then	NULL
one-fifth	NULL
vol	NULL
.	NULL

of	NULL
0.1	NULL
M	NULL
DMP	NULL
freshly	NULL
prepared	NULL
in	NULL
0.2	NULL
M	NULL
triethanolamine	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
10	NULL
°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
0.2	NULL
M	NULL
triethanolamine	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
to	NULL
block	NULL
any	NULL
remaining	NULL
unreacted	NULL
imidate	NULL
groups	NULL
.	NULL

Ligand	NULL
binding	NULL
assays	NULL
Ligand	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
[	NULL
11	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
crude	NULL
translation	NULL
medium	NULL
was	NULL
diluted	NULL
with	NULL
1	NULL
vol	NULL
.	NULL

of	NULL
ice-cold	NULL
TEGW	NULL
buffer	NULL
.	NULL

Aliquots	NULL
(	NULL
25	NULL
l	NULL
)	NULL
of	NULL
this	NULL
medium	NULL
were	NULL
incubated	NULL
for	NULL
4h	NULL
at	NULL
4°C	NULL
with	NULL
the	NULL
tritiated	NULL
ligand	NULL
at	NULL
a	NULL
saturating	NULL
concentration	NULL
(	NULL
10	NULL
nM	NULL
[	NULL
*HJaldosterone	NULL
or	NULL
10	NULL
nM	NULL
[	NULL
*HJprogesterone	NULL
)	NULL
.	NULL

mAb	NULL
18C7	NULL
was	NULL
added	NULL
as	NULL
described	NULL
and	NULL
incubated	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
4	NULL
h.	NULL
Non-specific	NULL
binding	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
wM	NULL
unlabelled	NULL
steroid	NULL
.	NULL

Bound	NULL
steroid	NULL
was	NULL
separated	NULL
from	NULL
free	NULL
steroid	NULL
by	NULL
using	NULL
the	NULL
dextran-charcoal	NULL
treatment	NULL
described	NULL
previously	NULL
[	NULL
5	NULL
]	NULL
.	NULL

After	NULL
the	NULL
addition	NULL
of	NULL
3	NULL
ml	NULL
of	NULL
Ultima	NULL
Gold	NULL
solution	NULL
(	NULL
Packard	NULL
,	NULL
Rungis	NULL
,	NULL
France	NULL
)	NULL
,	NULL
radioactivity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
Beckman	NULL
liquid-scintillation	NULL
counter	NULL
.	NULL

Sucrose	NULL
density	NULL
gradient	NULL
experiments	NULL
Sedimentation	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
linear	NULL
525	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
sucrose	NULL
gradient	NULL
prepared	NULL
in	NULL
TEG	NULL
or	NULL
TEGK	NULL
buffer	NULL
,	NULL
with	NULL
or	NULL
Antibody	NULL
to	NULL
the	NULL
mineralocorticoid	NULL
receptor	NULL
hormone-binding	NULL
domain	NULL
59	NULL
without	NULL
20	NULL
mM	NULL
tungstate	NULL
or	NULL
molybdate	NULL
ions	NULL
depending	NULL
on	NULL
the	NULL
experiment	NULL
.	NULL

Gradients	NULL
were	NULL
centrifuged	NULL
at	NULL
180000	NULL
g	NULL
in	NULL
a	NULL
SW41	NULL
rotor	NULL
(	NULL
Beckman	NULL
,	NULL
France	NULL
)	NULL
for	NULL
15	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
tube	NULL
had	NULL
been	NULL
pierced	NULL
,	NULL
three-drop	NULL
fractions	NULL
were	NULL
collected	NULL
and	NULL
radioactivity	NULL
was	NULL
counted	NULL
.	NULL

Catalase	NULL
(	NULL
C	NULL
,	NULL
11.3	NULL
S	NULL
)	NULL
,	NULL
aldolase	NULL
(	NULL
¥	NULL
,	NULL
7.9	NULL
$	NULL
)	NULL
and	NULL
BSA	NULL
(	NULL
B	NULL
,	NULL
4.6	NULL
S	NULL
)	NULL
were	NULL
used	NULL
as	NULL
external	NULL
sedimentation	NULL
markers	NULL
.	NULL

Transfection	NULL
of	NULL
COS-7	NULL
cells	NULL
COS-7	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
charcoal-treated	NULL
calf	NULL
serum	NULL
,	NULL
5	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
i.u./ml	NULL
penicillin	NULL
and	NULL
100	NULL
ug/l	NULL
streptomycin	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
plated	NULL
and	NULL
transfected	NULL
on	NULL
10	NULL
ug/ml	NULL
glass	NULL
coverslips	NULL
pretreated	NULL
with	NULL
poly	NULL
(	NULL
L-lysine	NULL
)	NULL
(	NULL
100000	NULL
cells	NULL
per	NULL
coverslip	NULL
)	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
pRShMR	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
n-	NULL
[	NULL
1	NULL
(	NULL
2,3-dioleoyloxy	NULL
)	NULL
propyl	NULL
]	NULL
-	NULL
N	NULL
,	NULL
N	NULL
,	NULL
N-trimethylammonium	NULL
methylsulphate	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Meylan	NULL
,	NULL
France	NULL
)	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
incubation	NULL
with	NULL
DNA	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
the	NULL
indicated	NULL
hormones	NULL
at	NULL
100	NULL
nM	NULL
final	NULL
concentration	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
fixed	NULL
for	NULL
15	NULL
min	NULL
in	NULL
4	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
,	NULL
rehydrated	NULL
by	NULL
three	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
permeabilized	NULL
with	NULL
1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Triton	NULL
X-100	NULL
in	NULL
PBS	NULL
for	NULL
1	NULL
min	NULL
.	NULL

After	NULL
additional	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
free	NULL
aldehydes	NULL
were	NULL
reduced	NULL
with	NULL
0.05	NULL
%	NULL
NaBH	NULL
,	NULL
in	NULL
PBS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
[	NULL
17	NULL
]	NULL
,	NULL
subsequently	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
2	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
calf	NULL
serum	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Immunohistochemistry	NULL
Sections	NULL
(	NULL
10	NULL
am	NULL
)	NULL
of	NULL
frozen	NULL
rabbit	NULL
kidney	NULL
were	NULL
cut	NULL
in	NULL
a	NULL
cryostat	NULL
at	NULL
-20	NULL
°C	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
below	NULL
.	NULL

Immunofluorescence	NULL
Treated	NULL
COS	NULL
cells	NULL
or	NULL
kidney	NULL
sections	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
mAb	NULL
18C7	NULL
as	NULL
primary	NULL
antibody	NULL
[	NULL
mAb	NULL
18C7	NULL
at	NULL
1:100	NULL
dilution	NULL
in	NULL
PBS	NULL
supplemented	NULL
with	NULL
0.05	NULL
%	NULL
Tween-20	NULL
and	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
]	NULL
.	NULL

Bound	NULL
antibody	NULL
was	NULL
detected	NULL
by	NULL
staining	NULL
with	NULL
a	NULL
fluorescein-conjugated	NULL
affinity-purified	NULL
goat	NULL
anti-	NULL
(	NULL
mouse	NULL
IgG	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
diluted	NULL
1	NULL
:	NULL
200	NULL
in	NULL
PBS	NULL
supplemented	NULL
with	NULL
0.05	NULL
%	NULL
Tween-20	NULL
and	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

A	NULL
Nikon	NULL
Optiphot-2	NULL
microscope	NULL
was	NULL
used	NULL
for	NULL
epifluorescence	NULL
microscopy	NULL
and	NULL
microphotography	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
Discontinuous	NULL
SDS/PAGE	NULL
[	NULL
10	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
gell	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Laemmli	NULL
[	NULL
18	NULL
]	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
Ecquevilly	NULL
,	NULL
France	NULL
)	NULL
in	NULL
a	NULL
Bio-Rad	NULL
Trans	NULL
Blot	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Ivry-sur-Seine	NULL
,	NULL
France	NULL
)	NULL
at	NULL
50	NULL
V	NULL
for	NULL
2	NULL
h	NULL
in	NULL
20	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
methanol/192	NULL
mM	NULL
glycine/0.1	NULL
%	NULL
SDS/25	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
.	NULL

After	NULL
transfer	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
blocked	NULL
with	NULL
3	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
non-fat	NULL
dried	NULL
milk	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
)	NULL
supplemented	NULL
with	NULL
0.05	NULL
%	NULL
Tween-20	NULL
.	NULL

Immunoblots	NULL
were	NULL
probed	NULL
with	NULL
mAb	NULL
18C7	NULL
(	NULL
1:1000	NULL
in	NULL
TBS	NULL
supplemented	NULL
with	NULL
0.05	NULL
%	NULL
Tween-20	NULL
and	NULL
3	NULL
%	NULL
non-fat	NULL
dried	NULL
milk	NULL
)	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
revealed	NULL
with	NULL
an	NULL
alkaline	NULL
phosphatase-conjugated	NULL
affinipure	NULL
rabbit	NULL
anti-	NULL
(	NULL
mouse	NULL
IgG	NULL
)	NULL
(	NULL
Jackson	NULL
,	NULL
Interchim	NULL
,	NULL
Montlugon	NULL
,	NULL
France	NULL
)	NULL
diluted	NULL
1	NULL
:	NULL
5000	NULL
in	NULL
TBS	NULL
supplemented	NULL
with	NULL
0.05	NULL
%	NULL
Tween-20	NULL
.	NULL

Autoradiography	NULL
After	NULL
electrophoresis	NULL
of	NULL
the	NULL
1-	NULL
[	NULL
**S	NULL
)	NULL
methionine-labelled	NULL
samples	NULL
by	NULL
discontinuous	NULL
SDS/PAGE	NULL
(	NULL
10	NULL
%	NULL
gel	NULL
)	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
fixed	NULL
in	NULL
7	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
acetic	NULL
acid	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Signals	NULL
were	NULL
enhanced	NULL
by	NULL
fluorography	NULL
:	NULL
the	NULL
gels	NULL
were	NULL
soaked	NULL
in	NULL
Amplify	NULL
for	NULL
30	NULL
min	NULL
then	NULL
rinsed	NULL
briefly	NULL
in	NULL
water	NULL
and	NULL
dried	NULL
down	NULL
.	NULL

They	NULL
were	NULL
exposed	NULL
to	NULL
autoradiography	NULL
on	NULL
Hyperfilm-MP	NULL
(	NULL
Amersham	NULL
)	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Anti-HBD	NULL
antibody	NULL
production	NULL
and	NULL
characterization	NULL
To	NULL
direct	NULL
the	NULL
immunogenic	NULL
response	NULL
towards	NULL
the	NULL
hMR	NULL
HBD	NULL
,	NULL
we	NULL
immunized	NULL
mice	NULL
with	NULL
the	NULL
recombinant	NULL
fusion	NULL
protein	NULL
GST-HBD	NULL
,	NULL
in	NULL
which	NULL
GST	NULL
is	NULL
linked	NULL
to	NULL
the	NULL
255	NULL
residues	NULL
of	NULL
HBD	NULL
(	NULL
Thr	NULL
``	NULL
**-Lys	NULL
``	NULL
*	NULL
)	NULL
,	NULL
which	NULL
was	NULL
previously	NULL
prepared	NULL
in	NULL
our	NULL
laboratory	NULL
[	NULL
9	NULL
]	NULL
.	NULL

Among	NULL
the	NULL
several	NULL
hybridomas	NULL
producing	NULL
antibodies	NULL
detected	NULL
by	NULL
ELISA	NULL
,	NULL
one	NULL
hybridoma	NULL
(	NULL
mAb	NULL
18C7	NULL
)	NULL
reacted	NULL
with	NULL
the	NULL
two	NULL
fusion	NULL
proteins	NULL
GST-HBD	NULL
and	NULL
MBP-HBD	NULL
,	NULL
but	NULL
not	NULL
with	NULL
GST	NULL
and	NULL
MBP	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
18C7	NULL
is	NULL
specific	NULL
to	NULL
the	NULL
HBD	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
mAb	NULL
18C7	NULL
with	NULL
denatured	NULL
HBD	NULL
was	NULL
examined	NULL
by	NULL
immunoblot	NULL
analysis	NULL
.	NULL

mAb	NULL
18C7	NULL
recognized	NULL
both	NULL
the	NULL
GST-HBD	NULL
(	NULL
55	NULL
kDa	NULL
;	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
MBP-HBD	NULL
(	NULL
70	NULL
kDa	NULL
;	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
but	NULL
no	NULL
bands	NULL
were	NULL
observed	NULL
with	NULL
GST	NULL
or	NULL
with	NULL
MBP	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
respectively	NULL
)	NULL
.	NULL

Some	NULL
additional	NULL
bands	NULL
corresponding	NULL
to	NULL
unidentified	NULL
degradation	NULL
products	NULL
were	NULL
observed	NULL
.	NULL

Because	NULL
the	NULL
high	NULL
similarity	NULL
in	NULL
the	NULL
HBD	NULL
sequences	NULL
of	NULL
both	NULL
hMR	NULL
and	NULL
human	NULL
GR	NULL
(	NULL
hGR	NULL
)	NULL
was	NULL
responsible	NULL
for	NULL
strong	NULL
cross-reactivities	NULL
between	NULL
the	NULL
two	NULL
receptors	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
antibody	NULL
reactivity	NULL
towards	NULL
hGR	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
provided	NULL
evidence	NULL
of	NULL
18C7	NULL
cross-reactivity	NULL
with	NULL
hGR	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Several	NULL
HBD	NULL
fragments	NULL
were	NULL
produced	NULL
(	NULL
see	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
)	NULL
to	NULL
fully	NULL
localize	NULL
the	NULL
epitope	NULL
recognized	NULL
by	NULL
18C7	NULL
.	NULL

These	NULL
fragments	NULL
were	NULL
HBD	NULL
mutants	NULL
deleted	NULL
at	NULL
the	NULL
N-terminal	NULL
end	NULL
,	NULL
at	NULL
the	NULL
C-terminal	NULL
end	NULL
or	NULL
at	NULL
both	NULL
ends	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
previously	NULL
published	NULL
results	NULL
by	NULL
Jalaguier	NULL
et	NULL
al	NULL
.	NULL

[	NULL
9	NULL
]	NULL
,	NULL
none	NULL
of	NULL
these	NULL
fragments	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
aldosterone	NULL
or	NULL
progesterone	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
immunoblot	NULL
analysis	NULL
,	NULL
mAb	NULL
18C7	NULL
recognized	NULL
only	NULL
the	NULL
fragments	NULL
including	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
107	NULL
-	NULL
»	NULL
wi	NULL
by	NULL
36.8	NULL
-	NULL
»	NULL
27.2-	NULL
»	NULL
19	NULL
=-	NULL
»	NULL
Figure	NULL
1	NULL
-	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
recombinant	NULL
MR	NULL
fragments	NULL
MR	NULL
fragments	NULL
were	NULL
expressed	NULL
as	NULL
fusion	NULL
proteins	NULL
with	NULL
GST	NULL
or	NULL
MBP	NULL
,	NULL
then	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
(	NULL
10	NULL
%	NULL
ge	NULL
!	NULL
)	NULL

and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Immunodetection	NULL
was	NULL
performed	NULL
with	NULL
18C7	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
GST-HBD	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
MBP-HBD	NULL
.	NULL

Langs	NULL
3	NULL
and	NULL
5	NULL
correspond	NULL
respectively	NULL
to	NULL
GST	NULL
and	NULL
MBP	NULL
deprived	NULL
of	NULL
any	NULL
fused	NULL
protein	NULL
.	NULL

Lanes	NULL
6-11	NULL
,	NULL
recombinant	NULL
HBD	NULL
fragments	NULL
fused	NULL
to	NULL
MBP	NULL
:	NULL
lane	NULL
6	NULL
,	NULL
Leu'®-Lys®	NULL
``	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
lane	NULL
8	NULL
,	NULL
lane	NULL
9	NULL
,	NULL
Leu'*	NULL
``	NULL
-Gly*	NULL
``	NULL
5	NULL
;	NULL
lang	NULL
10	NULL
,	NULL
Thr*	NULL
``	NULL
-Leu	NULL
'	NULL
``	NULL
;	NULL
lane	NULL
11	NULL
,	NULL
The	NULL
molecular	NULL
masses	NULL
(	NULL
in	NULL
kDa	NULL
)	NULL
of	NULL
the	NULL
protein	NULL
markers	NULL
in	NULL
lane	NULL
1	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

60	NULL
S.	NULL
Jalaguier	NULL
and	NULL
others	NULL
Figure	NULL
2	NULL
-	NULL
Immunodetection	NULL
of	NULL
MR	NULL
In	NULL
rabbit	NULL
kidney	NULL
cortex	NULL
by	NULL
18C7	NULL
Sections	NULL
were	NULL
immunostained	NULL
with	NULL
mAb	NULL
18C7	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
.	NULL

In	NULL
kidney	NULL
cortex	NULL
immunostaining	NULL
was	NULL
observed	NULL
along	NULL
the	NULL
collecting	NULL
tubules	NULL
(	NULL
CT	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
with	NULL
no	NULL
staining	NULL
in	NULL
the	NULL
glomerulus	NULL
(	NULL
GL	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Magnification	NULL
x	NULL
40.	NULL
the	NULL
HBD	NULL
,	NULL
e.g	NULL
.	NULL

fragments	NULL
Thr'*	NULL
%	NULL
-Glu®	NULL
``	NULL
*°	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
Thr	NULL
``	NULL
*	NULL
``	NULL
*-Gly*	NULL
``	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
and	NULL
Thr'*-Leu***	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

The	NULL
antibody	NULL
did	NULL
not	NULL
react	NULL
with	NULL
fragments	NULL
including	NULL
the	NULL
C	NULL
terminal	NULL
region	NULL
of	NULL
the	NULL
HBD	NULL
,	NULL
e.g	NULL
.	NULL

Leu	NULL
``	NULL
``	NULL
*-Lys®*	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
and	NULL
Leu**-Lys*	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

It	NULL
also	NULL
did	NULL
not	NULL
recognize	NULL
Leu	NULL
'	NULL
``	NULL
*-Gly*	NULL
``	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
central	NULL
region	NULL
of	NULL
the	NULL
HBD	NULL
.	NULL

These	NULL
results	NULL
highlighted	NULL
the	NULL
epitope	NULL
recognized	NULL
by	NULL
mAb	NULL
18C:7	NULL
along	NULL
the	NULL
hMBR	NULL
:	NULL
it	NULL
encompasses	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
HBD	NULL
from	NULL
Thr'*	NULL
``	NULL
to	NULL
Leu	NULL
``	NULL
.	NULL

With	NULL
an	NULL
immunohistochemical	NULL
technique	NULL
,	NULL
mAb	NULL
18C7	NULL
revealed	NULL
immunoreactive	NULL
structures	NULL
in	NULL
sections	NULL
of	NULL
rabbit	NULL
kidney	NULL
cortex	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
(	NULL
A	NULL
)	NULL
,	NULL
hMR	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
collecting	NULL
ducts	NULL
but	NULL
no	NULL
immunostaining	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
proximal	NULL
tubules	NULL
or	NULL
in	NULL
the	NULL
glomerulus	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

The	NULL
immunostaining	NULL
distribution	NULL
observed	NULL
with	NULL
18C7	NULL
was	NULL
in	NULL
close	NULL
agreement	NULL
with	NULL
that	NULL
revealed	NULL
by	NULL
other	NULL
anti-MR	NULL
antibodies	NULL
[	NULL
13,19	NULL
]	NULL
.	NULL

Similar	NULL
immunostaining	NULL
was	NULL
also	NULL
obtained	NULL
with	NULL
rat	NULL
kidney	NULL
sections	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
18C:7	NULL
,	NULL
an	NULL
anti-human	NULL
MR	NULL
,	NULL
to	NULL
interact	NULL
with	NULL
both	NULL
rabbit	NULL
and	NULL
rat	NULL
MR	NULL
demonstrated	NULL
its	NULL
interspecies	NULL
cross-reactivity	NULL
.	NULL

We	NULL
further	NULL
examined	NULL
the	NULL
labelling	NULL
of	NULL
hMR	NULL
by	NULL
18C7	NULL
in	NULL
transiently	NULL
transfected	NULL
COS-7	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
ligand	NULL
the	NULL
receptor	NULL
was	NULL
strongly	NULL
detected	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
conditions	NULL
of	NULL
our	NULL
experiment	NULL
,	NULL
after	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
aldosterone	NULL
,	NULL
hMR	NULL
was	NULL
revealed	NULL
by	NULL
18C:7	NULL
in	NULL
the	NULL
nucleus	NULL
only	NULL
,	NULL
where	NULL
the	NULL
receptor	NULL
is	NULL
supposed	NULL
to	NULL
be	NULL
in	NULL
its	NULL
transformed	NULL
DNA-bound	NULL
state	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
effect	NULL
was	NULL
observed	NULL
after	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
antagonist	NULL
progesterone	NULL
(	NULL
Figure	NULL
3D	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
experimental	NULL
conditions	NULL
,	NULL
18C7	NULL
confirmed	NULL
that	NULL
hMR	NULL
is	NULL
functionally	NULL
involved	NULL
in	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
mineralocorticoid	NULL
agonist	NULL
(	NULL
aldosterone	NULL
)	NULL
and	NULL
antagonist	NULL
(	NULL
progesterone	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
in	NULL
total	NULL
agreement	NULL
with	NULL
those	NULL
of	NULL
Robertson	NULL
et	NULL
al	NULL
.	NULL

[	NULL
13	NULL
]	NULL
,	NULL
even	NULL
though	NULL
Lombés	NULL
et	NULL
al	NULL
.	NULL

[	NULL
14	NULL
]	NULL
established	NULL
that	NULL
the	NULL
intracellular	NULL
distribution	NULL
of	NULL
hMR	NULL
expressed	NULL
in	NULL
High	NULL
Five	NULL
cells	NULL
was	NULL
differentially	NULL
regulated	NULL
by	NULL
aldosterone	NULL
and	NULL
anti-mineralocorticoids	NULL
.	NULL

Influence	NULL
of	NULL
mAb	NULL
18G7	NULL
on	NULL
steroid	NULL
binding	NULL
It	NULL
was	NULL
previously	NULL
demonstrated	NULL
that	NULL
the	NULL
hMR	NULL
expressed	NULL
in	NULL
vitro	NULL
in	NULL
reticulocyte	NULL
lysate	NULL
had	NULL
steroid-binding	NULL
properties	NULL
identical	NULL
with	NULL
those	NULL
of	NULL
the	NULL
native	NULL
receptor	NULL
[	NULL
11,20	NULL
]	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
mAb	NULL
18C:7	NULL
on	NULL
steroid	NULL
binding	NULL
was	NULL
examined	NULL
by	NULL
using	NULL
the	NULL
recombinant	NULL
full	NULL
Figure	NULL
3	NULL
Immunocytochemical	NULL
locallzation	NULL
of	NULL
hMR	NULL
transfected	NULL
Into	NULL
GCOS-7	NULL
cells	NULL
pRShMR-transfected	NULL
COS-7	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
B	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
100	NULL
nM	NULL
aldosterong	NULL
(	NULL
G	NULL
)	NULL
or	NULL
100	NULL
nM	NULL
progesterone	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
processed	NULL
for	NULL
immunofluorescence	NULL
by	NULL
using	NULL
18C7	NULL
antibody	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
.	NULL

Untreated	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
are	NULL
shown	NULL
as	NULL
controls	NULL
.	NULL

Magnification	NULL
x	NULL
200	NULL
.	NULL

Antibody	NULL
to	NULL
the	NULL
mineralocorticoid	NULL
receptor	NULL
hormone-binding	NULL
domain	NULL
61	NULL
100	NULL
L	NULL
~	NULL
on	NULL
L	NULL
[	NULL
*H	NULL
]	NULL
Hormone	NULL
bound	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
he	NULL
&	NULL
n	NULL
in	NULL
©	NULL
1	NULL
1	NULL
o	NULL
-//u	NULL
--	NULL
-	NULL
.	NULL

moremmp	NULL
--	NULL
--	NULL
rmy	NULL
102	NULL
102	NULL
10	NULL
1	NULL
Antibody	NULL
concentration	NULL
(	NULL
uM	NULL
)	NULL
Figure	NULL
4	NULL
-	NULL
Effect	NULL
of	NULL
mab	NULL
18C7	NULL
on	NULL
ligand	NULL
binding	NULL
to	NULL
MR	NULL
[	NULL
°HJAldosterons-MR	NULL
complexes	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
10	NULL
w	NULL
of	NULL
serial	NULL
dilutions	NULL
of	NULL
18C7	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
asl	NULL
(	NULL
@	NULL
)	NULL
.	NULL

hMR	NULL
was	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
10	NULL
a	NULL
!	NULL

of	NULL
serial	NULL
dilutions	NULL
of	NULL
18C7	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
second	NULL
incubation	NULL
with	NULL
10	NULL
nM	NULL
[	NULL
}	NULL
HJaldosterone	NULL
(	NULL
(	NULL
C	NULL
)	NULL
)	NULL
or	NULL
[	NULL
*H	NULL
Jprogesterone	NULL
(	NULL
w	NULL
)	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Non-specific	NULL
binding	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
M	NULL
unlabelled	NULL
steroid	NULL
.	NULL

Bound	NULL
and	NULL
free	NULL
steroid	NULL
were	NULL
separated	NULL
by	NULL
the	NULL
dextran-charcoal	NULL
technique	NULL
.	NULL

Results	NULL
are	NULL
means	NULL
of	NULL
four	NULL
separate	NULL
experiments	NULL
and	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
specific	NULL
[	NULL
PHJhormone	NULL
binding	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
antibody	NULL
.	NULL

hMR	NULL
expressed	NULL
in	NULL
a	NULL
reticulocyte	NULL
lysate	NULL
coupled	NULL
transcription-translation	NULL
system	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
two	NULL
incubation	NULL
conditions	NULL
were	NULL
examined	NULL
:	NULL
the	NULL
steroid	NULL
(	NULL
agonist	NULL
or	NULL
antagonist	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
hMR	NULL
either	NULL
before	NULL
or	NULL
after	NULL
incubation	NULL
with	NULL
18C7	NULL
.	NULL

hMR	NULL
was	NULL
first	NULL
incubated	NULL
with	NULL
10	NULL
nM	NULL
[	NULL
*HJaldosterone	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
and	NULL
the	NULL
aldosterone-hMR	NULL
complex	NULL
was	NULL
subsequently	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
mAb	NULL
18C7	NULL
.	NULL

The	NULL
antibody	NULL
was	NULL
able	NULL
to	NULL
displace	NULL
[	NULL
*HJaldosterone	NULL
binding	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

At	NULL
1	NULL
4M	NULL
18C7	NULL
,	NULL
20	NULL
%	NULL
of	NULL
the	NULL
bound	NULL
radioactivity	NULL
was	NULL
displaced	NULL
from	NULL
the	NULL
complex	NULL
.	NULL

A	NULL
similar	NULL
result	NULL
was	NULL
obtained	NULL
when	NULL
both	NULL
hormone	NULL
and	NULL
antibody	NULL
were	NULL
incubated	NULL
simultaneously	NULL
with	NULL
the	NULL
receptor	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
hMR	NULL
was	NULL
incubated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
18C7	NULL
before	NULL
incubation	NULL
with	NULL
[	NULL
*HJaldosterone	NULL
,	NULL
the	NULL
antibody	NULL
inhibited	NULL
aldosterone	NULL
binding	NULL
.	NULL

The	NULL
percentage	NULL
inhibition	NULL
of	NULL
bound	NULL
radioactivity	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
antibody	NULL
concentration	NULL
.	NULL

In	NULL
these	NULL
conditions	NULL
,	NULL
1	NULL
18C7	NULL
was	NULL
able	NULL
to	NULL
prevent	NULL
[	NULL
*HJaldosterone	NULL
binding	NULL
with	NULL
82	NULL
%	NULL
efficiency	NULL
of	NULL
inhibition	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
effect	NULL
of	NULL
18C7	NULL
was	NULL
observed	NULL
on	NULL
progesterone	NULL
binding	NULL
.	NULL

When	NULL
hMR	NULL
was	NULL
first	NULL
incubated	NULL
with	NULL
18C7	NULL
and	NULL
then	NULL
with	NULL
10	NULL
nM	NULL
steroid	NULL
binding	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
antibody	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
that	NULL
a	NULL
maximum	NULL
inhibitory	NULL
effect	NULL
of	NULL
75	NULL
%	NULL
was	NULL
induced	NULL
by	NULL
1	NULL
wM	NULL
18C7	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
when	NULL
incubated	NULL
with	NULL
hMR	NULL
,	NULL
mAb	NULL
18C7	NULL
was	NULL
able	NULL
to	NULL
block	NULL
the	NULL
access	NULL
of	NULL
both	NULL
aldosterone	NULL
and	NULL
progesterone	NULL
to	NULL
their	NULL
binding	NULL
site	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
.	NULL

Sucrose	NULL
density	NULL
gradient	NULL
analysis	NULL
The	NULL
ability	NULL
of	NULL
mAb	NULL
18C7	NULL
to	NULL
interact	NULL
with	NULL
native	NULL
hMR	NULL
was	NULL
further	NULL
determined	NULL
by	NULL
sucrose	NULL
density	NULL
gradient	NULL
analysis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
sodium	NULL
tungstate	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
stabilize	NULL
the	NULL
hetero-oligomeric	NULL
MR	NULL
form	NULL
[	NULL
5	NULL
]	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
that	NULL
the	NULL
tungstate-stabilized	NULL
hMR	NULL
labelled	NULL
with	NULL
10	NULL
nM	NULL
[	NULL
*HJaldosterone	NULL
sedimented	NULL
as	NULL
a	NULL
10.5	NULL
S	NULL
entity	NULL
.	NULL

When	NULL
the	NULL
[	NULL
*HJaldosteronc-MR	NULL
complex	NULL
was	NULL
incubated	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
mAb	NULL
18C:7	NULL
,	NULL
no	NULL
shift	NULL
was	NULL
observed	NULL
and	NULL
,	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
no	NULL
marked	NULL
«	NULL
<	NULL
-	NULL
m	NULL
<	NULL
-	NULL
&	NULL
10	NULL
%	NULL
x	NULL
[	NULL
HJaldosterone	NULL
bound	NULL
(	NULL
d.	NULL
p.	NULL
m.	NULL
)	NULL
0	NULL
0.4	NULL
0.8	NULL
Figure	NULL
5	NULL
-	NULL
mAb	NULL
18G7	NULL
does	NULL
not	NULL
co-sediment	NULL
with	NULL
the	NULL
[	NULL
°HJaldosterone-MR	NULL
complex	NULL
[	NULL
PH	NULL
]	NULL
JAldosterons-MR	NULL
complexes	NULL
(	NULL
100	NULL
&	NULL
!	NULL
)	NULL

recovered	NULL
in	NULL
TEGW	NULL
buffer	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
24	NULL
w	NULL
!	NULL

of	NULL
undiluted	NULL
control	NULL
ascites	NULL
(	NULL
(	NULL
)	NULL
or	NULL
with	NULL
6	NULL
w	NULL
!	NULL

(	NULL
&	NULL
)	NULL
or	NULL
24	NULL
wl	NULL
(	NULL
@	NULL
)	NULL
of	NULL
18C7	NULL
.	NULL

After	NULL
dextran-charcoal	NULL
treatment	NULL
,	NULL
a	NULL
100	NULL
w	NULL
!	NULL

aliquot	NULL
was	NULL
layered	NULL
on	NULL
top	NULL
of	NULL
a	NULL
5-25	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
sucrose	NULL
gradient	NULL
prepared	NULL
in	NULL
TEGW	NULL
buffer	NULL
.	NULL

Gradients	NULL
were	NULL
centrifuged	NULL
for	NULL
15	NULL
h	NULL
at	NULL
180000	NULL
g	NULL
in	NULL
a	NULL
SW41	NULL
rotor	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Sedimentation	NULL
markers	NULL
are	NULL
indicated	NULL
:	NULL
aldolase	NULL
(	NULL
a	NULL
,	NULL
7.9	NULL
S	NULL
)	NULL
and	NULL
BSA	NULL
(	NULL
b	NULL
,	NULL
4.6	NULL
S	NULL
)	NULL
.	NULL

decrease	NULL
in	NULL
the	NULL
bound	NULL
radioactivity	NULL
could	NULL
be	NULL
detected	NULL
whatever	NULL
the	NULL
amount	NULL
of	NULL
18C7	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
incubation	NULL
conditions	NULL
were	NULL
changed	NULL
(	NULL
18C7	NULL
was	NULL
first	NULL
incubated	NULL
with	NULL
hMR	NULL
and	NULL
then	NULL
with	NULL
[	NULL
*HJaldosterone	NULL
)	NULL
,	NULL
a	NULL
slight	NULL
decrease	NULL
(	NULL
30	NULL
%	NULL
)	NULL
in	NULL
bound	NULL
radioactivity	NULL
was	NULL
observed	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
antibody	NULL
did	NULL
not	NULL
co-sediment	NULL
with	NULL
the	NULL
[	NULL
*HJaldosterone-MR	NULL
complex	NULL
.	NULL

They	NULL
also	NULL
suggest	NULL
that	NULL
18C7	NULL
was	NULL
partly	NULL
able	NULL
to	NULL
block	NULL
the	NULL
access	NULL
of	NULL
aldosterone	NULL
to	NULL
its	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
the	NULL
above	NULL
experiments	NULL
,	NULL
the	NULL
liganded	NULL
hMR	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
[	NULL
*HJaldosterone	NULL
as	NULL
tracer	NULL
.	NULL

To	NULL
favour	NULL
the	NULL
concomitant	NULL
detection	NULL
of	NULL
both	NULL
the	NULL
unliganded	NULL
and	NULL
liganded	NULL
forms	NULL
of	NULL
the	NULL
receptor	NULL
,	NULL
hMR	NULL
was	NULL
metabolically	NULL
labelled	NULL
with	NULL
[	NULL
**S	NULL
}	NULL
methionine	NULL
during	NULL
its	NULL
expression	NULL
in	NULL
the	NULL
lysate	NULL
system	NULL
.	NULL

The	NULL
gradient	NULL
profiles	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
(	NULL
A	NULL
)	NULL
indicate	NULL
that	NULL
the	NULL
unliganded	NULL
[	NULL
*SJhMR	NULL
sedimented	NULL
at	NULL
10.5	NULL
S.	NULL
After	NULL
incubation	NULL
with	NULL
18C:7	NULL
,	NULL
the	NULL
peak	NULL
was	NULL
shifted	NULL
at	NULL
11.5	NULL
S	NULL
,	NULL
demonstrating	NULL
that	NULL
18C7	NULL
co-sedimented	NULL
with	NULL
native	NULL
unliganded	NULL
hMR	NULL
.	NULL

Figure	NULL
6	NULL
(	NULL
A	NULL
)	NULL
also	NULL
shows	NULL
that	NULL
the	NULL
sedimentation	NULL
profile	NULL
of	NULL
the	NULL
aldosterone-liganded	NULL
[	NULL
*SJhMR	NULL
matched	NULL
that	NULL
of	NULL
the	NULL
unliganded	NULL
hMR	NULL
with	NULL
a	NULL
sedimentation	NULL
coefficient	NULL
of	NULL
10.5	NULL
S.	NULL
Sedimentation	NULL
of	NULL
[	NULL
**SIhMBR	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
aldosterone	NULL
and	NULL
18C7	NULL
was	NULL
then	NULL
evaluated	NULL
by	NULL
incubating	NULL
the	NULL
antibody	NULL
first	NULL
and	NULL
then	NULL
the	NULL
steroid	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
two	NULL
overlapping	NULL
peaks	NULL
were	NULL
62	NULL
S.	NULL
Jalaguier	NULL
and	NULL
others	NULL
C	NULL
a	NULL
C	NULL
R	NULL
e	NULL
is	NULL
e	NULL
an	NULL
(	NULL
A	NULL
)	NULL
(	NULL
B	NULL
)	NULL
E	NULL
10-7	NULL
10	NULL
a.	NULL
k	NULL
3	NULL
8-	NULL
ac	NULL
a	NULL
o	NULL
-	NULL
6	NULL
2a	NULL
6	NULL
3	NULL
,	NULL
0	NULL
4	NULL
x	NULL
a	NULL
L	NULL
24	NULL
2-o	NULL
t	NULL
|	NULL
04	NULL
--	NULL
t	NULL
--	NULL
--	NULL
+	NULL
--	NULL
-0	NULL
02	NULL
%	NULL
04	NULL
_	NULL
0.6	NULL
o	NULL
02	NULL
%	NULL
04	NULL
_	NULL
0.6	NULL
A.	NULL
Ap	NULL
Figure	NULL
6	NULL
-	NULL
mAb	NULL
18C7	NULL
co-sediments	NULL
with	NULL
unliganded	NULL
MR	NULL
[	NULL
P°SJhMAR	NULL
,	NULL
synthesized	NULL
in	NULL
vifro	NULL
,	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ligand	NULL
(	NULL
A	NULL
,	NULL
O	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
nM	NULL
unlabelled	NULL
aldosterone	NULL
(	NULL
A	NULL
,	NULL
@	NULL
;	NULL
B	NULL
,	NULL
@	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
gl	NULL
of	NULL
18C7	NULL
(	NULL
A	NULL
,	NULL
A	NULL
;	NULL
B	NULL
,	NULL
A	NULL
)	NULL
[	NULL
PSINMR	NULL
(	NULL
B	NULL
,	NULL
CJ	NULL
)	NULL
was	NULL
incubated	NULL
first	NULL
with	NULL
20	NULL
pl	NULL
of	NULL
1807	NULL
and	NULL
then	NULL
with	NULL
10	NULL
nM	NULL
aldosterong	NULL
.	NULL

All	NULL
incubations	NULL
were	NULL
conducted	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
4	NULL
h.	NULL
A	NULL
100	NULL
_	NULL
!	NULL

aliquot	NULL
was	NULL
layered	NULL
on	NULL
top	NULL
of	NULL
a	NULL
5-25	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
sucrose	NULL
gradient	NULL
prepared	NULL
in	NULL
TEGW	NULL
buffer	NULL
.	NULL

Gradients	NULL
were	NULL
centrifuged	NULL
for	NULL
15	NULL
h	NULL
at	NULL
180.000	NULL
g	NULL
in	NULL
a	NULL
SW41	NULL
rotor	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Sedimentation	NULL
markers	NULL
are	NULL
indicated	NULL
:	NULL
catalase	NULL
(	NULL
c	NULL
,	NULL
11.3	NULL
S	NULL
)	NULL
and	NULL
aldolase	NULL
(	NULL
a	NULL
,	NULL
7.9	NULL
S	NULL
)	NULL
.	NULL

observed	NULL
at	NULL
approx	NULL
.	NULL

11.5	NULL
S	NULL
and	NULL
10.5	NULL
S	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
simultaneous	NULL
complexes	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
progesterone	NULL
,	NULL
18C7	NULL
had	NULL
a	NULL
similar	NULL
effect	NULL
on	NULL
hMR	NULL
:	NULL
a	NULL
large	NULL
shoulder	NULL
encompassing	NULL
both	NULL
forms	NULL
of	NULL
the	NULL
com-plexed	NULL
receptor	NULL
was	NULL
observed	NULL
at	NULL
approx	NULL
.	NULL

11	NULL
S	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
overall	NULL
results	NULL
indicate	NULL
that	NULL
18C7	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
aldosterone-binding	NULL
site	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
that	NULL
of	NULL
progesterone	NULL
.	NULL

Covalent	NULL
cross-linking	NULL
As	NULL
the	NULL
association	NULL
of	NULL
hsps	NULL
such	NULL
as	NULL
hsp90	NULL
with	NULL
hMR	NULL
is	NULL
required	NULL
for	NULL
a	NULL
competent	NULL
steroid-binding	NULL
site	NULL
[	NULL
6,9	NULL
]	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
determine	NULL
whether	NULL
18C7	NULL
acted	NULL
directly	NULL
on	NULL
the	NULL
steroid-binding	NULL
site	NULL
or	NULL
through	NULL
hsp	NULL
binding	NULL
.	NULL

hMR	NULL
and	NULL
its	NULL
associated	NULL
proteins	NULL
were	NULL
thus	NULL
covalently	NULL
linked	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
18C7	NULL
on	NULL
steroid	NULL
binding	NULL
was	NULL
examined	NULL
by	NULL
gradient	NULL
analysis	NULL
.	NULL

We	NULL
covalently	NULL
cross-linked	NULL
the	NULL
receptor-associated	NULL
proteins	NULL
on	NULL
with	NULL
DMP	NULL
,	NULL
an	NULL
irreversible	NULL
cross-linking	NULL
reagent	NULL
that	NULL
was	NULL
demonstrated	NULL
to	NULL
promote	NULL
covalent	NULL
binding	NULL
between	NULL
the	NULL
chick	NULL
MR	NULL
and	NULL
hsp90	NULL
without	NULL
altering	NULL
aldosterone	NULL
binding	NULL
[	NULL
5	NULL
]	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
efficiency	NULL
of	NULL
coupling	NULL
in	NULL
our	NULL
assays	NULL
,	NULL
a	NULL
parallel	NULL
experiment	NULL
was	NULL
conducted	NULL
with	NULL
the	NULL
hsp-deprived	NULL
transformed	NULL
hMBR	NULL
state	NULL
.	NULL

The	NULL
gradient	NULL
analyses	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
sodium	NULL
molybdate	NULL
,	NULL
which	NULL
allows	NULL
hMR	NULL
transformation	NULL
at	NULL
high	NULL
salt	NULL
concentrations	NULL
(	NULL
0.4	NULL
M	NULL
KCI	NULL
]	NULL
)	NULL
[	NULL
5	NULL
]	NULL
.	NULL

Under	NULL
low	NULL
salt	NULL
conditions	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
,	NULL
the	NULL
molybdate-stabilized	NULL
[	NULL
*	NULL
``	NULL
SJhMR	NULL
sedimented	NULL
at	NULL
10	NULL
S.	NULL
After	NULL
treatment	NULL
with	NULL
DMP	NULL
,	NULL
the	NULL
cross-linked	NULL
hMR	NULL
sedimented	NULL
at	NULL
the	NULL
same	NULL
position	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
cross-linked	NULL
hMR	NULL
was	NULL
subsequently	NULL
incubated	NULL
with	NULL
18C7	NULL
,	NULL
the	NULL
peak	NULL
shifted	NULL
from	NULL
10	NULL
S	NULL
to	NULL
118	NULL
.	NULL

This	NULL
shift	NULL
was	NULL
identical	NULL
with	NULL
that	NULL
observed	NULL
after	NULL
the	NULL
incubation	NULL
of	NULL
untreated	NULL
hMR	NULL
with	NULL
18C7	NULL
.	NULL

Under	NULL
high	NULL
salt	NULL
conditions	NULL
(	NULL
0.4	NULL
M	NULL
KCI	NULL
;	NULL
Figure	NULL
7B	NULL
)	NULL
,	NULL
the	NULL
non-cross-linked	NULL
hMR	NULL
incubated	NULL
with	NULL
18C7	NULL
sedimented	NULL
at	NULL
8.8	NULL
S	NULL
,	NULL
whereas	NULL
the	NULL
cross-linked	NULL
hMR	NULL
,	NULL
after	NULL
incubation	NULL
with	NULL
18C:7	NULL
,	NULL
had	NULL
10x	NULL
[	NULL
°°SIMR	NULL
bound	NULL
(	NULL
d.	NULL
p.	NULL
m.	NULL
)	NULL
04	NULL
0.6	NULL
0.8	NULL
Ae	NULL
Figure	NULL
7	NULL
mAb	NULL
18C7	NULL
reacts	NULL
with	NULL
the	NULL
cross-linked	NULL
MR	NULL
synthesized	NULL
/n	NULL
vifro	NULL
,	NULL
was	NULL
incubated	NULL
in	NULL
TEG	NULL
containing	NULL
20	NULL
mM	NULL
sodium	NULL
molybdate	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Q	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
20	NULL
asl	NULL
of	NULL
18C7	NULL
(	NULL
)	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
DMP	NULL
,	NULL
[	NULL
°°SJhMR	NULL
was	NULL
incubated	NULL
with	NULL
20	NULL
w	NULL
!	NULL

of	NULL
18C7	NULL
(	NULL
[	NULL
Q	NULL
]	NULL
)	NULL
.	NULL

A	NULL
100	NULL
pl	NULL
aliquot	NULL
was	NULL
layered	NULL
on	NULL
top	NULL
of	NULL
a	NULL
5-25	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
sucrose	NULL
gradient	NULL
prepared	NULL
in	NULL
TEGMo	NULL
buffer	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sample	NULL
aliquots	NULL
were	NULL
incubated	NULL
as	NULL
in	NULL
(	NULL
)	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.4	NULL
M	NULL
KCI	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analysed	NULL
on	NULL
sucrose	NULL
gradients	NULL
containing	NULL
molybdate	NULL
and	NULL
0.4	NULL
M	NULL
KCI	NULL
.	NULL

Gradients	NULL
were	NULL
centrifuged	NULL
for	NULL
15	NULL
h	NULL
at	NULL
180000	NULL
g	NULL
in	NULL
a	NULL
SW41	NULL
rotor	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Sedimentation	NULL
markers	NULL
are	NULL
indicated	NULL
:	NULL
catalase	NULL
(	NULL
c	NULL
,	NULL
11.3	NULL
S	NULL
)	NULL
,	NULL
aldolase	NULL
(	NULL
a	NULL
,	NULL
7.9	NULL
S	NULL
)	NULL
and	NULL
BSA	NULL
(	NULL
b	NULL
,	NULL
4.6	NULL
S	NULL
)	NULL
.	NULL

shifted	NULL
to	NULL
form	NULL
a	NULL
large	NULL
peak	NULL
at	NULL
approx	NULL
.	NULL

10.5	NULL
S.	NULL
As	NULL
a	NULL
control	NULL
for	NULL
the	NULL
transformation	NULL
process	NULL
,	NULL
the	NULL
non-cross-linked	NULL
hMR	NULL
was	NULL
analysed	NULL
under	NULL
high	NULL
salt	NULL
conditions	NULL
.	NULL

No	NULL
peak	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
area	NULL
because	NULL
of	NULL
the	NULL
large	NULL
amount	NULL
of	NULL
free	NULL
[	NULL
®SImethionine	NULL
.	NULL

Fractions	NULL
corresponding	NULL
to	NULL
the	NULL
10.5	NULL
S	NULL
peak	NULL
,	NULL
the	NULL
8.8	NULL
S	NULL
peak	NULL
and	NULL
the	NULL
masked	NULL
area	NULL
at	NULL
approx	NULL
.	NULL

4-5	NULL
S	NULL
were	NULL
then	NULL
analysed	NULL
by	NULL
autoradiography	NULL
after	NULL
SDS/PAGE	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

Fractions	NULL
5-15	NULL
(	NULL
peak	NULL
at	NULL
10.5	NULL
S	NULL
)	NULL
migrated	NULL
as	NULL
a	NULL
250	NULL
kDa	NULL
entity	NULL
,	NULL
which	NULL
corresponded	NULL
well	NULL
to	NULL
the	NULL
hMR	NULL
cross-linked	NULL
with	NULL
hsps	NULL
.	NULL

Fractions	NULL
10-16	NULL
(	NULL
peak	NULL
at	NULL
8.8	NULL
S	NULL
)	NULL
mainly	NULL
migrated	NULL
at	NULL
110	NULL
kDa	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
was	NULL
the	NULL
transformed	NULL
form	NULL
of	NULL
the	NULL
receptor	NULL
that	NULL
was	NULL
recognized	NULL
by	NULL
18C:7	NULL
.	NULL

Fractions	NULL
12-20	NULL
migrated	NULL
as	NULL
a	NULL
major	NULL
110	NULL
kDa	NULL
entity	NULL
(	NULL
peak	NULL
at	NULL
approx	NULL
.	NULL

58	NULL
according	NULL
to	NULL
the	NULL
auto-radiograph	NULL
pattern	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
transformed	NULL
hMBR	NULL
state	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
18C7	NULL
recognition	NULL
of	NULL
hMR	NULL
was	NULL
not	NULL
hindered	NULL
by	NULL
cross-linked	NULL
proteins	NULL
such	NULL
as	NULL
hsps	NULL
.	NULL

They	NULL
also	NULL
demonstrate	NULL
that	NULL
18C7	NULL
was	NULL
able	NULL
to	NULL
react	NULL
with	NULL
the	NULL
4	NULL
S	NULL
transformed	NULL
hMBR	NULL
state	NULL
.	NULL

The	NULL
overall	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
demonstrate	NULL
that	NULL
the	NULL
new	NULL
mAb	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
(	NULL
18C:7	NULL
)	NULL
,	NULL
raised	NULL
against	NULL
the	NULL
HBD	NULL
of	NULL
h	NULL
MBR	NULL
,	NULL
recognized	NULL
both	NULL
the	NULL
denatured	NULL
and	NULL
native	NULL
hMR	NULL
forms	NULL
.	NULL

It	NULL
also	NULL
reacted	NULL
with	NULL
both	NULL
the	NULL
hetero-oligomeric	NULL
10	NULL
S	NULL
$	NULL
structure	NULL
of	NULL
the	NULL
receptor	NULL
as	NULL
well	NULL
as	NULL
the	NULL
transformed	NULL
4	NULL
S	NULL
state	NULL
.	NULL

It	NULL
then	NULL
provided	NULL
an	NULL
important	NULL
tool	NULL
for	NULL
direct	NULL
examination	NULL
of	NULL
the	NULL
HBD	NULL
structure	NULL
and	NULL
function	NULL
.	NULL

When	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antibody	NULL
was	NULL
tested	NULL
on	NULL
hormone	NULL
binding	NULL
,	NULL
18C:7	NULL
seriously	NULL
impaired	NULL
both	NULL
aldosterone	NULL
and	NULL
progesterone	NULL
binding	NULL
.	NULL

When	NULL
incubated	NULL
before	NULL
the	NULL
steroid	NULL
,	NULL
mAb	NULL
18C7	NULL
was	NULL
able	NULL
to	NULL
prevent	NULL
75-80	NULL
%	NULL
of	NULL
hormone	NULL
binding	NULL
to	NULL
hMR	NULL
.	NULL

Furthermore	NULL
the	NULL
sucrose	NULL
density	NULL
gradient	NULL
analysis	NULL
revealed	NULL
the	NULL
concomitant	NULL
presence	NULL
of	NULL
two	NULL
complexes	NULL
with	NULL
hMR	NULL
:	NULL
the	NULL
steroid	NULL
hMR	NULL
complex	NULL
and	NULL
the	NULL
antibody-hMR	NULL
complex	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
steroid-hMR-antibody	NULL
was	NULL
ruled	NULL
out	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
18C7	NULL
did	NULL
not	NULL
co-sediment	NULL
with	NULL
the	NULL
liganded	NULL
[	NULL
*HJaldosterone-hMR	NULL
.	NULL

As	NULL
18C7	NULL
was	NULL
able	NULL
to	NULL
react	NULL
in	NULL
a	NULL
similar	NULL
way	NULL
with	NULL
the	NULL
hMR	NULL
,	NULL
cross-linked	NULL
or	NULL
not	NULL
with	NULL
the	NULL
hsps	NULL
,	NULL
our	NULL
results	NULL
Antibody	NULL
to	NULL
the	NULL
mineralocorticoid	NULL
receptor	NULL
hormone-binding	NULL
domain	NULL
63	NULL
A	NULL
B	NULL
C	NULL
Fraction	NULL
S	NULL
$	NULL
6	NULL
7	NULL
&	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
1	NULL
%	NULL
16	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
kD	NULL
220	NULL
-m	NULL
nee	NULL
®t	NULL
*	NULL
97	NULL
-	NULL
-am	NULL
hac	NULL
n	NULL
.	NULL

‘	NULL
h	NULL
66	NULL
-	NULL
»	NULL
46	NULL
--	NULL
30	NULL
-	NULL
»	NULL
Figure	NULL
8	NULL
-	NULL
Mab	NULL
18C7	NULL
Interacts	NULL
with	NULL
the	NULL
transformed	NULL
hMR	NULL
state	NULL
The	NULL
collected	NULL
*°S-labelled	NULL
fractions	NULL
of	NULL
the	NULL
high-salt	NULL
(	NULL
0.4	NULL
M	NULL
KCI	NULL
)	NULL
gradients	NULL
corresponding	NULL
to	NULL
the	NULL
10.5	NULL
S	NULL
peak	NULL
(	NULL
M	NULL
)	NULL
,	NULL
the	NULL
8.8	NULL
S	NULL
peak	NULL
(	NULL
B	NULL
)	NULL
and	NULL
the	NULL
area	NULL
at	NULL
approx	NULL
.	NULL

4	NULL
S	NULL
to	NULL
5	NULL
S	NULL
(	NULL
C	NULL
)	NULL
detected	NULL
in	NULL
Figure	NULL
7	NULL
(	NULL
B	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
(	NULL
10	NULL
%	NULL
gel	NULL
)	NULL
.	NULL

After	NULL
fixation	NULL
and	NULL
enhancement	NULL
of	NULL
signals	NULL
by	NULL
fluorography	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
an	NULL
autoradiography	NULL
film	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
(	NULL
in	NULL
kDa	NULL
)	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
left	NULL
.	NULL

clearly	NULL
demonstrate	NULL
that	NULL
the	NULL
18C7	NULL
epitope	NULL
,	NULL
located	NULL
in	NULL
the	NULL
N-terminal	NULL
part	NULL
of	NULL
the	NULL
HBD	NULL
,	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
steroid	NULL
binding	NULL
.	NULL

It	NULL
is	NULL
now	NULL
agreed	NULL
that	NULL
the	NULL
hormone-binding	NULL
pocket	NULL
of	NULL
steroid	NULL
receptors	NULL
is	NULL
made	NULL
up	NULL
of	NULL
residues	NULL
from	NULL
throughout	NULL
the	NULL
HBD	NULL
.	NULL

Furthermore	NULL
it	NULL
had	NULL
been	NULL
previously	NULL
suggested	NULL
that	NULL
aldosterone	NULL
and	NULL
spironolactone	NULL
bound	NULL
to	NULL
a	NULL
common	NULL
site	NULL
[	NULL
21	NULL
]	NULL
.	NULL

These	NULL
hypotheses	NULL
are	NULL
strengthened	NULL
by	NULL
our	NULL
present	NULL
study	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
three	NULL
HBD	NULL
mutants	NULL
with	NULL
the	NULL
N-terminal	NULL
sequence	NULL
deleted	NULL
were	NULL
unable	NULL
to	NULL
bind	NULL
aldosterone	NULL
or	NULL
progesterone	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
clearly	NULL
that	NULL
the	NULL
Thr*	NULL
``	NULL
``	NULL
-Leu	NULL
``	NULL
``	NULL
``	NULL
sequence	NULL
is	NULL
part	NULL
of	NULL
a	NULL
module	NULL
involved	NULL
in	NULL
the	NULL
joint	NULL
binding	NULL
of	NULL
agonists	NULL
and	NULL
antagonists	NULL
.	NULL

Recently	NULL
,	NULL
Wurtz	NULL
et	NULL
al	NULL
.	NULL

[	NULL
22	NULL
]	NULL
proposed	NULL
a	NULL
canonical	NULL
structure	NULL
for	NULL
the	NULL
ligand-binding	NULL
domain	NULL
of	NULL
the	NULL
whole	NULL
nuclear	NULL
receptor	NULL
family	NULL
:	NULL
the	NULL
anti-parallel	NULL
«	NULL
-helical	NULL
sandwich	NULL
.	NULL

From	NULL
their	NULL
report	NULL
,	NULL
six	NULL
helices	NULL
(	NULL
H3	NULL
to	NULL
H5	NULL
and	NULL
H8	NULL
to	NULL
H10	NULL
)	NULL
form	NULL
the	NULL
core	NULL
of	NULL
the	NULL
ligand-binding	NULL
domain	NULL
of	NULL
retinoic	NULL
acid	NULL
receptors	NULL
.	NULL

As	NULL
a	NULL
comparison	NULL
with	NULL
this	NULL
model	NULL
,	NULL
the	NULL
hMR	NULL
sequence	NULL
Thr'*	NULL
``	NULL
-Leu	NULL
``	NULL
``	NULL
includes	NULL
helix	NULL
H1	NULL
,	NULL
the	NULL
loop	NULL
between	NULL
H1	NULL
and	NULL
H3	NULL
,	NULL
and	NULL
the	NULL
first	NULL
three	NULL
amino	NULL
acids	NULL
of	NULL
helix	NULL
H3	NULL
.	NULL

Although	NULL
not	NULL
directly	NULL
implicated	NULL
in	NULL
the	NULL
six	NULL
helices	NULL
constituting	NULL
the	NULL
core	NULL
binding	NULL
site	NULL
,	NULL
this	NULL
region	NULL
encompasses	NULL
H1	NULL
,	NULL
which	NULL
is	NULL
supposed	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
key	NULL
contacts	NULL
with	NULL
the	NULL
ligand-binding	NULL
core	NULL
through	NULL
five	NULL
amino	NULL
acid	NULL
residues	NULL
(	NULL
Leu	NULL
,	NULL
Glu	NULL
``	NULL
,	NULL
Ne	NULL
``	NULL
,	NULL
Glu	NULL
``	NULL
and	NULL
Ne	NULL
``	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
H1	NULL
,	NULL
the	NULL
hMR	NULL
sequence	NULL
Thr'**-Leu	NULL
``	NULL
*	NULL
``	NULL
also	NULL
comprises	NULL
the	NULL
loop	NULL
between	NULL
H1	NULL
and	NULL
H3	NULL
,	NULL
which	NULL
is	NULL
probably	NULL
involved	NULL
in	NULL
bending	NULL
H3	NULL
during	NULL
ligand	NULL
binding	NULL
.	NULL

It	NULL
would	NULL
now	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
site	NULL
recognized	NULL
by	NULL
18C7	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
receptor	NULL
conformation	NULL
or	NULL
whether	NULL
there	NULL
are	NULL
direct	NULL
contacts	NULL
with	NULL
the	NULL
steroid	NULL
.	NULL

We	NULL
thank	NULL
:	NULL
Dr.	NULL
Jean	NULL
Léger	NULL
for	NULL
his	NULL
constructive	NULL
and	NULL
helpful	NULL
comments	NULL
on	NULL
this	NULL
manuscript	NULL
;	NULL
Dr.	NULL
Frangoise	NULL
Pons	NULL
for	NULL
her	NULL
assistance	NULL
with	NULL
the	NULL
immunohistochemistry	NULL
;	NULL
Anne-Marie	NULL
Cathiard	NULL
for	NULL
her	NULL
help	NULL
with	NULL
COS	NULL
cell	NULL
transfection	NULL
;	NULL
Danielle	NULL
Mesnier	NULL
for	NULL
excellent	NULL
skilful	NULL
assistance	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
recombinant	NULL
proteins	NULL
in	NULL
£	NULL
.	NULL

coff	NULL
;	NULL
and	NULL
Patrick	NULL
Atger	NULL
for	NULL
skilful	NULL
photographic	NULL
work	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
French	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
.	NULL

Received	NULL
14	NULL
October	NULL
1996/10	NULL
January	NULL
1997	NULL
;	NULL
accepted	NULL
16	NULL
January	NULL
1997	NULL
REFERENCES	NULL
1	NULL
-	NULL
Arriza	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Weinberger	NULL
,	NULL
C.	NULL
,	NULL
Cerelli	NULL
,	NULL
G.	NULL
,	NULL
Glaser	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Handelin	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Housman	NULL
,	NULL
D.	NULL
E.	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
237	NULL
,	NULL
268-275	NULL
2	NULL
-	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
889-895	NULL
Tsai	NULL
,	NULL
M.-J	NULL
.	NULL

and	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
,	NULL
451-486	NULL
4	NULL
-	NULL
Jalaguier	NULL
,	NULL
S.	NULL
,	NULL
Mornet	NULL
,	NULL
D.	NULL
,	NULL
Mesnier	NULL
,	NULL
D.	NULL
,	NULL
Léger	NULL
,	NULL
J.	NULL
J.	NULL
and	NULL
Auzou	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

384	NULL
,	NULL
112-116	NULL
5	NULL
-	NULL
Rafestin-Oblin	NULL
,	NULL
M.-E.	NULL
,	NULL
Couette	NULL
,	NULL
B.	NULL
,	NULL
Radanyi	NULL
,	NULL
C.	NULL
,	NULL
Lombés	NULL
,	NULL
M.	NULL
and	NULL
Baulieu	NULL
,	NULL
E.	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
9304-9309	NULL
6	NULL
-	NULL
Caamano	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Morano	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Patel	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Watson	NULL
,	NULL
S.	NULL
J.	NULL
and	NULL
Akil	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Biochemistry	NULL
32	NULL
,	NULL
8589-8595	NULL
7	NULL
-	NULL
Pratt	NULL
,	NULL
W.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21455-21458	NULL
8	NULL
-	NULL
Smith	NULL
,	NULL
D.	NULL
F.	NULL
and	NULL
Toft	NULL
,	NULL
D.	NULL
0	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

7	NULL
,	NULL
4-11	NULL
9	NULL
-	NULL
Jalaguier	NULL
,	NULL
S.	NULL
,	NULL
Mesnier	NULL
,	NULL
D.	NULL
,	NULL
Léger	NULL
,	NULL
J.	NULL
J.	NULL
and	NULL
Auzou	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

57	NULL
,	NULL
43-50	NULL
10	NULL
-	NULL
Trapp	NULL
,	NULL
T.	NULL
and	NULL
Holsboer	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

215	NULL
,	NULL
286-291	NULL
11	NULL
-	NULL
Couette	NULL
,	NULL
B.	NULL
,	NULL
Fagart	NULL
,	NULL
J.	NULL
,	NULL
Jalaguier	NULL
,	NULL
S.	NULL
,	NULL
Lombés	NULL
,	NULL
M.	NULL
,	NULL
Sougue	NULL
,	NULL
A.	NULL
and	NULL
Rafestin-Oblin	NULL
,	NULL
M.-E.	NULL
(	NULL
1996	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

315	NULL
,	NULL
421-427	NULL
12	NULL
-	NULL
Fukushima	NULL
,	NULL
K.	NULL
,	NULL
Sasano	NULL
,	NULL
H.	NULL
,	NULL
Nagura	NULL
,	NULL
H.	NULL
,	NULL
Sasaki	NULL
,	NULL
I.	NULL
,	NULL
Matsuno	NULL
,	NULL
S.	NULL
and	NULL
Krozowski	NULL
,	NULL
Z.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Tohoku	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165	NULL
,	NULL
155-163	NULL
13	NULL
-	NULL
Robertson	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Schulman	NULL
,	NULL
G.	NULL
,	NULL
Karnik	NULL
,	NULL
S.	NULL
,	NULL
Alnemri	NULL
,	NULL
E.	NULL
and	NULL
Litwack	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

7	NULL
,	NULL
1226-1239	NULL
14	NULL
-	NULL
Lombés	NULL
,	NULL
M.	NULL
,	NULL
Binart	NULL
,	NULL
N.	NULL
,	NULL
Delahaye	NULL
,	NULL
F.	NULL
,	NULL
Beaulieu	NULL
,	NULL
E.	NULL
E.	NULL
and	NULL
Rafestin-Oblin	NULL
,	NULL
M.-E.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

302	NULL
,	NULL
191-197	NULL
15	NULL
-	NULL
Krozowski	NULL
,	NULL
Z.	NULL
S.	NULL
,	NULL
Rundle	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Wallace	NULL
,	NULL
C.	NULL
,	NULL
Castell	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Shen	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Dowling	NULL
,	NULL
J.	NULL
,	NULL
Funder	NULL
,	NULL
J.	NULL
W.	NULL
and	NULL
Smith	NULL
,	NULL
A.	NULL
I	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Endocrinology	NULL
(	NULL
Baltimore	NULL
)	NULL
125	NULL
,	NULL
192-198	NULL
16	NULL
-	NULL
Lombés	NULL
,	NULL
M.	NULL
,	NULL
Edelman	NULL
,	NULL
1	NULL
.	NULL

S.	NULL
and	NULL
Erlanger	NULL
,	NULL
B.	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
2528-2536	NULL
17	NULL
-	NULL
Moneman	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Rindt	NULL
,	NULL
H.	NULL
,	NULL
Robbins	NULL
,	NULL
J.	NULL
and	NULL
Winkelmann	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
4	NULL
,	NULL
1051-1067	NULL
18	NULL
-	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
227	NULL
,	NULL
680-685	NULL
19	NULL
-	NULL
Farman	NULL
,	NULL
N.	NULL
,	NULL
Oblin	NULL
,	NULL
M.-E.	NULL
,	NULL
Lombés	NULL
,	NULL
M.	NULL
,	NULL
Delahaye	NULL
,	NULL
F.	NULL
,	NULL
Westphal	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Bonvalet	NULL
,	NULL
J.	NULL
P.	NULL
and	NULL
Gasc	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

280	NULL
,	NULL
©226-C233	NULL
20	NULL
-	NULL
Schulman	NULL
,	NULL
G.	NULL
,	NULL
Daniel	NULL
,	NULL
V.	NULL
,	NULL
Cooper	NULL
,	NULL
M.	NULL
,	NULL
Alnemri	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Maksymowych	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
and	NULL
Litwack	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Receptor	NULL
2	NULL
,	NULL
181-193	NULL
21	NULL
-	NULL
Couette	NULL
,	NULL
B.	NULL
,	NULL
Lombés	NULL
,	NULL
M.	NULL
,	NULL
Beaulieu	NULL
,	NULL
E.	NULL
E.	NULL
and	NULL
Rafestin-Oblin	NULL
,	NULL
M.-E.	NULL
(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

282	NULL
,	NULL
697-702	NULL
22	NULL
-	NULL
Wurtz	NULL
,	NULL
J-M.	NULL
,	NULL
Bourguet	NULL
,	NULL
W.	NULL
,	NULL
Renaud	NULL
,	NULL
J.-P.	NULL
,	NULL
Vivat	NULL
,	NULL
V.	NULL
,	NULL
Chambon	NULL
,	NULL
P.	NULL
,	NULL
Moras	NULL
,	NULL
D.	NULL
and	NULL
Gronemeyer	NULL
,	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
Struct	NULL
.	NULL

Biol	NULL
.	NULL

3	NULL
,	NULL
87-94	NULL
co	NULL

